Among the targets of ADAMs, inflammatory cytokines such as tumor necrosis factor-α (TNF-a) and their receptors such as interleukin-6 receptor play critical roles in liver inflammation and HCC development [101]. This evidence concerns the gene IL6R and hepatocellular carcinoma.